“…The drugs which, so far, have been implicated to induce torsade de pointes ventricular tachycardia are cardioactive agents such as quinidine (Rainier-Pope et al, 1962;Seizer andWray, 1964), procainamide (McCord andTaguchi, 1951;Castellanos and Salhanick, 1967), and lignocaine (Krikler and Curry, 1976a), antianginal drugs such as prenylamine (Puritz et al, 1977) and amiodarone (Bens et al, 1973), psychotropic agents (Fowler et al, 1976), such as phenothiazines (chlorpromazine, thioridazine, trifluoperazine, mesoridazine) and tricyclic antidepressants (amitriptyline, imipramine, protriptiline, nortriptyline,) diuretics, corticosteroids and glycyrrhizin (Bens et al, 1973), which induce hypokalaemia. Torsade de pointes can complicate (Krikler and Curry, 1976) myocardial ischaemia (Prinzmetal's variant angina, myocardial infarction), electrolytic deficits (hypokalaemia, hypomagnesaemia), acquired heart disease (myocarditis, coronary arteriosclerosis), slow basic rhythm (sino-atrial disease, high degree AV block), electrical ventricular stimulation and congenital disorders with deafness (Jervell-Lange-Nielsen syndrome, Romano-Ward-Barlow syndrome) with apparent (or only after exercise as a forme fruste) QT prolongation (Bernuth et al, 1973).…”